Huons Global Co., Ltd. (KOSDAQ:084110)

Market Cap	396.60B -35.8%
Revenue (ttm)	847.45B +4.2%
Net Income	28.84B +11.8%
EPS	2,360.00 +11.7%
Shares Out	12.20M
PE Ratio	13.77
Forward PE	n/a
Dividend	880.00 (2.47%)
Ex-Dividend Date	May 26, 2026

Volume	241,846
Average Volume	155,500
Open	35,250
Previous Close	35,650
Day's Range	31,550 - 35,500
52-Week Range	31,800 - 76,700
Beta	0.61
RSI	26.60
Earnings Date	May 12, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 118
• Stock Exchange: KOSDAQ
• Ticker Symbol: 084110

Financial Performance

In 2025, Huons Global's revenue was 847.45 billion, an increase of 4.18% compared to the previous year's 813.46 billion. Earnings were 28.84 billion, an increase of 11.82%.